Amsterdam institute for Immunology and Infectious diseases
AI&I news
PAIS IMPACT | The Dutch Lyme Disease Expertise Center: From Research to Real-World Impact At the Amsterdam institute for Immunology and Infectious diseases (AI&I), we focus our research and outreach on three key themes: Post-Acute Infection Syndrome (PAIS), Immunomonitoring, and Vaccination. Each quarter, we highlight one of these areas through a dedicated series of articles. This quarter (Q4 2025), our spotlight is on PAIS. In this article, we focus on the impact of PAIS research, with special attention to the work of the Dutch Lyme Disease Expertise Center (NLe).
PAIS RESEARCH | Challenges and Developments in PAIS Research with Jeroen den DunnenAt the Amsterdam institute for Immunology and Infectious diseases (AI&I), we are committed to advancing research in three key areas: Post-Acute Infection Syndrome (PAIS), Immunomonitoring, and Vaccination. Each quarter, we highlight one of these areas through a dedicated series of articles. This quarter (Q4 2025), our spotlight is on PAIS. In this article, we focus on the recent advances, ongoing challenges, and future directions in research on Post-Acute Infection Syndromes (PAIS) together with dr. Jeroen den Dunnen.
PAIS TOPIC 101 | With Brent Appelman At the Amsterdam institute for Immunology and Infectious diseases (AI&I), we are proud of the diverse and impactful research taking place across our institute. To provide direction and focus, we have identified three focus areas where we aim to stimulate and organize research for greater impact: PAIS, Immunomonitoring, and Vaccination.
In Q3 2025, the spotlight is on Post-Acute Infection Syndrome (PAIS). In this article, written in collaboration with AI&I researcher Brent Appelman, we explore the topic in depth.
